BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haupt S, Rubinstein A. The colon as a possible target for orally administered peptide and protein drugs. Crit Rev Ther Drug Carrier Syst. 2002;19:499-551. [PMID: 12822734 DOI: 10.1615/critrevtherdrugcarriersyst.v19.i6.10] [Cited by in Crossref: 51] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Mazzucchelli S, Corsi F. Diabetes management strategies: can nanoparticles be used to therapeutically deliver insulin? Ther Deliv 2017;8:49-51. [PMID: 28088882 DOI: 10.4155/tde-2016-0081] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Dahan A, Tsume Y, Sun J, Miller JM, Amidon GL. Oral Bioavailability of Peptide and Peptidomimetic Drugs. In: Hughes AB, editor. Amino Acids, Peptides and Proteins in Organic Chemistry. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2011. pp. 277-92. [DOI: 10.1002/9783527631827.ch8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Sharpe LA, Daily AM, Horava SD, Peppas NA. Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv 2014;11:901-15. [PMID: 24848309 DOI: 10.1517/17425247.2014.902047] [Cited by in Crossref: 167] [Cited by in F6Publishing: 135] [Article Influence: 20.9] [Reference Citation Analysis]
4 Gao SQ, Lu ZR, Kopecková P, Kopecek J. Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice. J Control Release 2007;117:179-85. [PMID: 17150276 DOI: 10.1016/j.jconrel.2006.10.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
5 Gazzaniga A, Cerea M, Cozzi A, Foppoli A, Maroni A, Zema L. A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers. AAPS PharmSciTech 2011;12:295-303. [PMID: 21267684 DOI: 10.1208/s12249-011-9581-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
6 Gao SQ, Sun Y, Kopecková P, Peterson CM, Kopecek J. Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats. Pharm Res 2008;25:218-26. [PMID: 17929146 DOI: 10.1007/s11095-007-9465-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
7 Wu T, Zheng WL, Zhang SZ, Sun JH, Yuan H. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice. World J Gastroenterol 2011; 17(31): 3614-3622 [PMID: 21987608 DOI: 10.3748/wjg.v17.i31.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
8 Subudhi MB, Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A, Jain SK. Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil. Materials (Basel) 2015;8:832-49. [PMID: 28787974 DOI: 10.3390/ma8030832] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 9.3] [Reference Citation Analysis]
9 Ghanbari-Movahed M, Kaceli T, Mondal A, Farzaei MH, Bishayee A. Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review. Biomedicines 2021;9:480. [PMID: 33925750 DOI: 10.3390/biomedicines9050480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]